Plasma protein signature of idiopathic pulmonary fibrosis (IPF)

被引：0
|
作者：
Kossen, Karl [1 ]
Qin, Xiaoli [1 ]
Lim, Sharlene [1 ]
Bradford, Williamson [1 ]
Deterding, Robin [2 ]
Seiwert, Scott [1 ]
机构：
[1] InterMune Inc, Res, Brisbane, CA USA
[2] Univ Colorado, Dept Pediat, Aurora, CO USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Idiopathic pulmonary fibrosis; Biomarkers;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3535
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients
    Ronan, Nicola
    Khan, Kashif A.
    Subramaniam, Abirami
    McCarthy, Yvonne
    Burke, Louise
    Chelliah, A.
    Plant, Barry J.
    Henry, Michael T.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [22] Could Hepcidin Be a New Biomarker in Patients with Idiopathic Pulmonary Fibrosis (IPF)?
    Yilmaz, Gulcin
    Coban, Hikmet
    Sarioglu, Nurhan
    Erel, Fuat
    Yilmaz, Merve Akis
    Colak, Mustafa
    Senel, Merve Yumrukuz
    Hismiogullari, Adnan Adil
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [23] Pathophysiology of small airways in idiopathic pulmonary fibrosis (IPF): the silent zone
    Lu, Wenying
    Shahzad, Affan Mahmood
    Simon, Athul Antony
    Haug, Greg
    Waters, Maddison
    Sohal, Sukhwinder Singh
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2025, 19 (03) : 195 - 203
  • [24] Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
    Gao, Jing
    Kalafatis, Dimitrios
    Carlson, Lisa
    Li, Chuan-Xing
    Pesonen, Ida
    Skold, Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [25] Serum ST2 in Idiopathic Pulmonary Fibrosis (IPF): a possible new biomarker of disease?
    Cavalli, Francesco
    Puxeddu, Ermanno
    Cillis, Giuseppe
    Teodori, Elisa
    Perrone, Marco
    Rogliani, Paola
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [26] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [27] Development of a patient reported experience measure (PREM) for idiopathic pulmonary fibrosis (IPF)
    Russell, Anne-Marie
    Datta, Arnab
    Newell, Karen
    Jones, Stephen
    Conway, John
    Saktkoo, Lesley Anne
    Wickremasinghe, Melissa
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [28] A potential three-gene-based diagnostic signature for idiopathic pulmonary fibrosis
    Wu, Yi
    Zhong, Lin
    Qiu, Li
    Dong, Liqun
    Yang, Lin
    Chen, Lina
    FRONTIERS IN GENETICS, 2023, 13
  • [29] Lung function of idiopathic pulmonary fibrosis: Russian IPF registry (Moscow region)
    Cherniak, Alexander
    Avdeev, Sergey
    Belevsky, Andrey
    Chikina, Svetlana
    Merzhoeva, Zamira
    Terpigorev, Stanislav
    Nekludova, Galina
    Tyurin, Igor
    Kravchenko, Natalia
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [30] Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
    Noble, Paul W.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    du Bois, Roland M.
    Fishman, Robert S.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Lederer, David
    Leff, Jonathan A.
    Nathan, Steven D.
    Pereira, Carlos A.
    Swigris, Jeffrey J.
    Valeyre, Dominique
    King, Talmadge E.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345